Rapid Micro Biosystems RPID
NASDAQ RPID
$1.66 -0.04 (-2.06%)
At close: Aug 20, 2026 · 2:16 PM UTC

Rapid Micro Biosystems (RPID) Other Non-Current Liabilities (2020 - 2026)

Rapid Micro Biosystems (RPID) posted Other Non-Current Liabilities of $340000.0 for Q1 2026, down 14.36% sequentially from $397000.0 in Q4 2025, and up 11.11% YoY from $306000.0 in Q1 2025.

Rapid Micro Biosystems (RPID) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends

Rapid Micro Biosystems has reported Other Non-Current Liabilities for 7 years, with the latest figure at $340000.0 in Q1 2026.

  • Quarterly Other Non-Current Liabilities rose 11.11% year-over-year to $340000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $340000.0 (up 11.11% YoY) and the FY2025 annual result came in at $397000.0, changed N/A from the prior year.
  • Other Non-Current Liabilities declined to $340000.0 in Q1 2026 per RPID's latest filing, from $397000.0 in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $735000.0 in Q1 2022 and troughed at $221000.0 in Q3 2022.
  • A 5-year average of $339062.5 and a median of $285000.0 in 2024 frame the typical range for Other Non-Current Liabilities.
  • The sharpest annual moves came in 2022 and 2025: Other Non-Current Liabilities slumped 95.53% in 2022, then climbed 17.65% in 2025.
  • Over 5 years, Other Non-Current Liabilities stood at $229000.0 in 2022, then gained by 14.85% to $263000.0 in 2023, then grew by 9.89% to $289000.0 in 2024, then jumped by 37.37% to $397000.0 in 2025, then declined by 14.36% to $340000.0 in 2026.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $340000.0, $397000.0, and $340000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 199.49 Bn 193.88 Bn 7.27 Bn
2 Stryker 127.80 Bn 124.32 Bn 4.50 Bn
3 Medtronic 118.98 Bn 109.76 Bn 6.41 Bn
4 Boston Scientific 73.58 Bn 73.04 Bn 3.85 Bn
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn
6 Dexcom 34.34 Bn 32.39 Bn 830.00 Mn
7 GE HealthCare Technologies 33.76 Bn 31.66 Bn 2.18 Bn
8 Koninklijke Philips 26.37 Bn 23.05 Bn 4.55 Bn
9 Steris 23.07 Bn 22.59 Bn 684.20 Mn
10 Rapid Micro Biosystems 80.50 Mn 60.73 Mn 1.21 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 348,000.00
Mar 31, 2026 340,000.00
Dec 31, 2025 397,000.00
Sep 30, 2025 340,000.00
Jun 30, 2025 314,000.00
Mar 31, 2025 306,000.00
Sep 30, 2024 289,000.00
Jun 30, 2024 281,000.00
Mar 31, 2024 272,000.00
Dec 31, 2023 263,000.00
Sep 30, 2023 255,000.00
Jun 30, 2023 247,000.00
Mar 31, 2023 238,000.00
Dec 31, 2022 229,000.00
Sep 30, 2022 221,000.00
Jun 30, 2022 698,000.00
Mar 31, 2022 735,000.00
Dec 31, 2021 1.21 Mn
Sep 30, 2021 1.23 Mn
Jun 30, 2021 15.60 Mn